english.prescrire.org > Spotlight > Archives : 2023 > Impending changes to European pharmaceutical regulations: part II

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2023 : 1 | 30 | 60

Impending changes to European pharmaceutical regulations: part II

 ADVANCING HEALTHCARE POLICY  In order to prepare its new "Pharmaceutical Strategy for Europe", the European Commission organised several public consultations in advance. The present article reproduces extensive excerpts from a report published by the European Parliamentary Research Service, produced in connection with these consultations, which calls for the creation of a "European Medicines Infrastructure".
Full article (3 pages) available for free download

  • The report published by the European Parliamentary Research Service analyses the strengths and weaknesses of the current pharmaceutical research and development (R&D) model in Europe. It then proposes a new approach to pharmaceutical policy, including the creation of a Europe-­wide public R&D infrastructure.
     
  • Future Prescrire articles will address the announced revisions of the EU's general pharmaceutical legislation and legislation on rare diseases and paediatric drugs.

©Prescrire 1 January 2023

Source: "Impending changes to European pharmaceutical regulations: part II" Prescrire International 2023; 32 (244): 23-25. Free.

Enjoy full access to Prescrire International, and support independent information

Share
Share on  Facebook Share on  Twitter


See also:

Advancing healthcare policy
Free

"Impending changes
to European pharmaceutical
regulations: part I"
Prescrire Int 2022;
31 (243): 302-304.
Pdf, free


Read more:

All the subjects in
Prescrire's Spotlight
Free >